Who is TGA head John Skerritt and why did he ban Ivermectin?

The head of the TGA is Professor John Skerritt. He has played a huge role in Australia’s health response to COVID-19, but Skerritt has never treated a patient himself and his background is not in medicine.

Dr John Skerritt is the National Manager of the Therapeutic Goods Administration (TGA). But did you know he has a bachelor’s degree in science, majoring in agriculture? Skerritt is not a medical doctor and has never treated any patients. He has no clinical experience with COVID-19.

Skerritt obtained a PhD in Pharmacology, but for the next 20 years, he focussed his research and writings on wheat. An expert on wheat is approving vaccines and making decisions on COVID-19 treatments for Australians. Before being appointed as the TGA head in 2012, Skerritt was Deputy Secretary of Primary Industries, Victoria. Yes, agriculture again.

John Skerritt’s Ban on Ivermectin

On September 10th, 2021, Professor John Skerritt made it no longer possible for GPs in Australia to prescribe Ivermectin for COVID-19. Previously, doctors were able to prescribe the drug off-label for patients suffering from the disease. The TGA’s statement on its ban of Ivermectin can be found here.

An excellent review of the TGA’s decision by England’s Dr John Campbell can be viewed below.

The first reason given on the TGA’s website for their extraordinary announcement was that:

"The Department is concerned that there are a number of significant public health risks associated with this practice including, for example, that persons taking Ivermectin in an effort to prevent COVID-19 consider themselves to be protected against the disease, elect not to be vaccinated as part of the national COVID-19 vaccination program, and chose not to get tested or seek medical care if they experience symptoms."

So Ivermectin is dangerous because it creates vaccine hesitancy?

The Efficacy of Ivermectin Triple Therapy

What happened in the lead up to this extraordinary decision on September 10th?

There was a group of Australian doctors treating patients in Sydney and Melbourne in July, August, and September with a protocol called the Ivermectin Triple Therapy (ITT). This therapy was a combination of repurposed drugs: Ivermectin, doxycycline, and zinc. The treatment program was an amazing success.

Out of 600 patients treated, only five were admitted to hospital, and there were zero deaths. An equivalent control group of 600 patients not treated with triple therapy resulted in 70 hospital admissions and six deaths. This is real-world data.

Did John Skerritt know about this Australian trial? Was that a factor in his September 10th decision?